Canine 1-DAPPv+L4
Provides effective protection against several common viruses and enhanced quality in leptospirosis protection by using the VacciPure™ filtration process.
Product Description
CANINE 1-DAPPv+L4 helps keep dogs healthy
Canine Distemper Virus, Canine Adenovirus Type 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses), Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona (inactivated bacterin).
- Effective against all known strains of canine parvovirus (CPV), including CPV-2c2,3
- Contains CPV-2b, one of the most prevalent field strains of parvovirus
- High antigenic mass (titer), low passage parvovirus vaccine
- The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch’s titer and quantity of colostral antibodies absorbed by the puppy.
- The only leptospirosis vaccine proven effective against mortality and urinary shedding.
- Prevented mortality caused by 4 virulent Leptospira serovars.1
- Effective against adenovirus type 1 that causes hepatitis in dogs.
- Proven effective against commonly spread canine viruses, distemper, adenovirus type 1 (hepatitis), parainfluenza and parvovirus, in 1 formula.
Indications:
Shown to be effective for vaccination of healthy dogs 8 weeks of age or older against canine distemper virus, canine adenovirus type 1 (hepatitis), canine parainfluenza virus, canine parvovirus, L. grippotyphosa, L. pomona, L. icterohaemorrhagiae, and L. canicola. Also effective against mortality and leptospiruria (shedding of Leptospira in the urine) caused by L. canicola,
L. icterohaemorrhagiae, L. pomona and L. grippotyphosa.
CANINE 1-DAPPV+L4 IS A SAFE CHOICE
- Safety confirmed in 749-dog field study1
- Proven safe across a variety of dog breeds and ages
- Featuring an even higher level of quality due to VacciPure™ filtration
ADMINISTRATION AND DOSAGE
- Subcutaneous injection
- Two 1 mL doses given 2 to 4 weeks apart
- Contact your veterinarian or manufacturer for more information on revaccination frequency
ALSO AVAILABLE IN OTHER FORMULATIONS
DISEASE INFORMATION
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
View More Nobivac ResourcesReferences
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global